Navigation Links
Science Finds Healing in Halloween Horrors
Date:10/30/2009

ing lizards known as Gila monsters. Byetta (exenatide), a diet drug which in one trial helped overweight people with diabetes shed an average of 11 pounds over three years, was based on the spit of the venomous striped lizard.

Other slithery, slimy creatures have their good side. Researchers at the University of Wisconsin-Madison are probing whether ingesting parasitic "helminth" whipworm eggs (in capsule form) can combat the flare-ups associated with relapsing-remitting multiple sclerosis. It sounds yucky, but scientists reckon that letting the eggs hatch in the intestine could trigger a favorable immune response in patients. The worms normally live in pigs.

Next up: maggots and leeches. Both have been approved as bona fide "medical devices" by the U.S. Food and Drug Administration to clean up wounds, although they're called "medical maggots" and "medicinal leeches" in scientific circles. In 2005, an FDA panel voted to classify both organisms as "non-exempt, Class II medical devices with special controls." In the case of the maggots, the special "controls" referred to instructions to prevent "escape of adult flies," and, in the case of leeches, a guidance document stating that "discarded leeches should be treated as biohazard waste due [to] their contact with blood."

Halloween isn't all monstrous, of course. On "treats" side of the holiday, keep in mind that the sugar in your candy bag has been used for millennia as an antibiotic.

"Huge clinical trials show that putting honey or sugar on antibiotic-resistant infections of the skin will often kill the bacteria," Root-Bernstein said. "This is one of the oldest treatments that exists. The reason it works is the same reason that sugar protects jelly from going bad. Basically, sugar is a preservative is the simple explanation. The more technical explanation is 'osmotic pressure.' Bacteria and fungi can't grow on something that has a high sugar content because the sugar sucks all
'/>"/>

Copyright©2009 ScoutNews,LLC.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Registration Closes Soon for FDAs Second Annual Science Writers Symposium
2. GCI ConnectMD Links Swedish Medical Center Neuroscience Stroke Specialists and Patients Throughout Washington State to Swedish's Joint Commission Certified Primary Stroke Center
3. FDA Issues Guidance for Derma Sciences Exclusive Wound Dressing With pDADMAC
4. Science at the petascale: Roadrunner results unveiled
5. Paging All Science and Medical Mavens: Get To Philadelphia Stat for Body Worlds and Beyond
6. Caliper Life Sciences Third Quarter 2009 Financial Results Conference Call Notice
7. Sangamo BioSciences Announces Presentation of Top-Line Statistically Significant Phase 2 Data in Diabetic Neuropathy at Society for Neuroscience Meeting
8. Photos: First-of-Its-Kind Website Unveiled at Modern Moms Meet Modern Science Meeting
9. Science study: Teacher participation in Columbia program improves student achievement in science
10. Yerkes researchers present at 39th Annual Society for Neuroscience Conference
11. Experts Summarize State of the Science in Autism Disorders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... Kicking blog MichaelHusted.com is featuring an ... his role as a kicking coach, his kicking business, and ... to retired NFL kicker Michael Husted author of HustedKicking.com. , ... is one of the top pro free agent kickers out ... Anthony at our 2014 Pro Camp and I was impressed ...
(Date:9/2/2014)... Tuesday 2 September 2014: The fact that mechanical heart ... confirmed by data from the ROPAC registry presented for ... Line session by Professor Jolien W. Roos-Hesselink, co-chair with ... registry found that 1.4% of pregnant women with a ... during pregnancy. , The Registry Of Pregnancy And Cardiac ...
(Date:9/2/2014)... “Harmonicas have been formally used in ... help people with COPD or asthma. At this ... says Dana Keller, PhD, co-inventor of the Pulmonica. ... much the same – improved health with the ... , The three approaches to harmonicas in healthcare ...
(Date:9/2/2014)... Fast hosting is a great choice for webmasters ... web hosting suppliers and announced that Arvixe, Bluehost and ... “It is hard to find a good fast hosting ... hosting features, uptime, server speed and customer support. People ... a manager of Top10BestSEOHosting.com says. , Arvixe has a ...
(Date:9/1/2014)... (PRWEB) September 02, 2014 NAPW ... Apex Healthcare, LLC as a 2014 Professional Woman of ... distinction for leadership in office management. As the largest, ... spanning virtually every industry and profession, the National Association ... with over 600,000 members and nearly 300 Local Chapters. ...
Breaking Medicine News(10 mins):Health News:MichaelHusted.com Features Interview with Anthony Cantele of Cantele Kicking on His Role as a Kicking Coach and on Becoming a National Camp Series (NCS) Associate 2Health News:MichaelHusted.com Features Interview with Anthony Cantele of Cantele Kicking on His Role as a Kicking Coach and on Becoming a National Camp Series (NCS) Associate 3Health News:Mechanical heart valves increase pregnancy risk 2Health News:Mechanical heart valves increase pregnancy risk 3Health News:Harmonica Techs, Inventor of the Pulmonica Pulmonary Harmonica, Outlines New Uses for Harmonicas in Healthcare 2Health News:Harmonica Techs, Inventor of the Pulmonica Pulmonary Harmonica, Outlines New Uses for Harmonicas in Healthcare 3Health News:Top10BestSEOHosting.com Recommends Fast Web Hosting Suppliers 2Health News:National Association of Professional Women Announces Victoria Smith, Office Manager at Apex Healthcare, LLC, a 2014 Professional Woman of the Year 2
... Components Corporation (ICC), an established global leader in ... a new series of high-efficiency AC-DC external power ... devices. Marketed under the Elpac Power Systems brand, ... company,s rapidly expanding portfolio of high-efficiency, high-reliability power ...
... Now Have Access to Low-Price Generic Options, Helping Consumers ... Stores Inc. (WMT) today announced its list of up ... will now be accessible to physicians using an Epocrates ... device. Physicians will now be better equipped to ...
... in Light of Economic Downturn, According to New ... HealthLeaders-InterStudy, a leading provider of managed care ... efforts in Louisiana and Rhode Island will likely ... downturn, particularly as Medicaid populations grow.According to the ...
... MOUNTAIN VIEW, Calif., Feb. 19 Based on its ... Frost & Sullivan recognizes Horphag Research Ltd. with the ... of the Year Award. The award acknowledges the company,s ... 40 years, aimed at validating the health benefits of ...
... Inc. (Nasdaq: CADX ) announced today that it ... shares of the Company,s common stock at a price of ... approximately 6 million additional shares of the Company,s common stock, ... of $7.84 per share, for aggregate gross proceeds of approximately ...
... - Defyrus Inc. today announced the signing an ... by the United Kingdom,s Defence Science and Technology ... Dstl,s commercialization company. These patents form the intellectual ... programs. Defyrus and Ploughshare Innovation Ltd plan to ...
Cached Medicine News:Health News:Elpac Power System 150-Watt Commercial External Power Supply Features Industry-Leading Efficiency and Power Density 2Health News:Wal-Mart's $4 Generic Prescription Drug List Added to Epocrates' Drug Reference Application 2Health News:Wal-Mart's $4 Generic Prescription Drug List Added to Epocrates' Drug Reference Application 3Health News:Medicaid Reform Efforts Underway in Louisiana and Rhode Island 2Health News:Medicaid Reform Efforts Underway in Louisiana and Rhode Island 3Health News:Frost & Sullivan Recognizes Horphag's Pioneering R&D Efforts in Health Ingredients 2Health News:Frost & Sullivan Recognizes Horphag's Pioneering R&D Efforts in Health Ingredients 3Health News:Frost & Sullivan Recognizes Horphag's Pioneering R&D Efforts in Health Ingredients 4Health News:Cadence Pharmaceuticals Completes $86.6 Million Private Placement of Common Stock 2Health News:Cadence Pharmaceuticals Completes $86.6 Million Private Placement of Common Stock 3Health News:Vaccine patent portfolio licensed from UK Ministry of Defence 2
(Date:9/2/2014)... According to a new market ... Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 ... of 10.1% from 2014 to 2020. Biological ... used in the treatment and prevention of various diseases ... medical disorders. Biological drugs include therapeutic proteins, monoclonal antibody ...
(Date:9/2/2014)... Calif. , Sept. 2, 2014 /PRNewswire-iReach/ -- ... just recognized as one of the fastest growing ... past few years, the company has undergone significant ... research, late phase global clinical development, anti-viral and ... 2 years, WCCT Global has successfully participated in ...
(Date:9/1/2014)... 1, 2014 Research and Markets ... Minimally-Invasive Biomarkers in Alzheimer,s Disease: A Comprehensive Analysis and ... report to their offering. This report ... developments relating to early-stage minimally-invasive biomarkers in Alzheimer,s disease, ... and candidates in the AD drug pipeline, and applicable ...
Breaking Medicine Technology:CAGR of 10.1% Global Biological Drugs Market - Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 to 2020: Report by MarketResearchReports.Biz 2CAGR of 10.1% Global Biological Drugs Market - Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 to 2020: Report by MarketResearchReports.Biz 3CAGR of 10.1% Global Biological Drugs Market - Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 to 2020: Report by MarketResearchReports.Biz 4CAGR of 10.1% Global Biological Drugs Market - Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 to 2020: Report by MarketResearchReports.Biz 5CAGR of 10.1% Global Biological Drugs Market - Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 to 2020: Report by MarketResearchReports.Biz 6Contract Research Organization WCCT Global Celebrates Being Named as One of the Fastest Growing Companies in America 2Early-Stage Minimally-Invasive Biomarkers in Alzheimer's Disease: A Comprehensive Analysis and Market Study of New Developments and Opportunities, 2014 2
... ANX ) today announced that the U.S. Food and Drug Administration (FDA) has accepted the proposed proprietary name "Exelbine™" for the Company,s product candidate ANX-530 (vinorelbine injectable emulsion). , ... , ... ... ...
... Ardea Biosciences, Inc. (Nasdaq: RDEA ) a biotechnology company focused on the development of small-molecule ... fourth quarter and full-year 2009 financial results and provided key upcoming clinical development milestones and financial guidance ... ... , ...
Cached Medicine Technology:ADVENTRX Receives Brand Name Acceptance for ANX-530 2ADVENTRX Receives Brand Name Acceptance for ANX-530 3ADVENTRX Receives Brand Name Acceptance for ANX-530 4Ardea Biosciences Reports Recent Accomplishments; Provides 2010 Outlook; Announces Fourth Quarter and Full-Year 2009 Financial Results and 2010 Financial Guidance 2Ardea Biosciences Reports Recent Accomplishments; Provides 2010 Outlook; Announces Fourth Quarter and Full-Year 2009 Financial Results and 2010 Financial Guidance 3Ardea Biosciences Reports Recent Accomplishments; Provides 2010 Outlook; Announces Fourth Quarter and Full-Year 2009 Financial Results and 2010 Financial Guidance 4Ardea Biosciences Reports Recent Accomplishments; Provides 2010 Outlook; Announces Fourth Quarter and Full-Year 2009 Financial Results and 2010 Financial Guidance 5Ardea Biosciences Reports Recent Accomplishments; Provides 2010 Outlook; Announces Fourth Quarter and Full-Year 2009 Financial Results and 2010 Financial Guidance 6Ardea Biosciences Reports Recent Accomplishments; Provides 2010 Outlook; Announces Fourth Quarter and Full-Year 2009 Financial Results and 2010 Financial Guidance 7Ardea Biosciences Reports Recent Accomplishments; Provides 2010 Outlook; Announces Fourth Quarter and Full-Year 2009 Financial Results and 2010 Financial Guidance 8Ardea Biosciences Reports Recent Accomplishments; Provides 2010 Outlook; Announces Fourth Quarter and Full-Year 2009 Financial Results and 2010 Financial Guidance 9Ardea Biosciences Reports Recent Accomplishments; Provides 2010 Outlook; Announces Fourth Quarter and Full-Year 2009 Financial Results and 2010 Financial Guidance 10Ardea Biosciences Reports Recent Accomplishments; Provides 2010 Outlook; Announces Fourth Quarter and Full-Year 2009 Financial Results and 2010 Financial Guidance 11
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: